I think Big Pharma's first instinct is to play defense here
Try to poke holes in the results, blame the mineral oil, hope it's all on the soft MACE side, etc
So they will sniff and fuss until AHA, and hope for weaknesses to exploit
If AHA is a smack-down, that's when Big Pharma will throw in the towel, and start throwing money at the problem -- that is to say, start throwing money at AMRN shareholders to buy this thing
It's going to be hard for AMRN not to get bought, IMO. The numbers will be pretty big.